Subramanian Natesan Selected Research

Subramanian Natesan Research Topics

Disease

5	Neoplasms (Cancer) 03/2021 - 11/2017
4	Macular Degeneration (Age-Related Maculopathy) 05/2023 - 08/2017
4	Breast Neoplasms (Breast Cancer) 04/2018 - 12/2014
3	Inflammation (Inflammations) 01/2020 - 12/2018
2	Lung Neoplasms (Lung Cancer) 03/2021 - 11/2019
2	Rheumatoid Arthritis 02/2020 - 12/2019
2	Glaucoma 11/2017 - 02/2017
1	Asthma (Bronchial Asthma) 01/2020
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2020
1	Hyperplasia 01/2020
1	Respiratory Hypersensitivity 01/2020
1	Arthritis (Polyarthritis) 12/2019
1	Bacterial Infections (Bacterial Infection) 12/2019
1	Disease Progression 12/2019
1	Hemolysis 10/2019
1	Eye Diseases (Eye Disease) 08/2017

Drug/Important Bio-Agent (IBA)

5	ChitosanIBA 03/2018 - 02/2017
3	CamptothecinIBA 04/2018 - 12/2014
2	calcium phosphateIBA 03/2021 - 11/2019
2	Lumefantrine FDA Link 03/2021 - 11/2019
2	Methotrexate (Mexate)FDA LinkGeneric 02/2020 - 12/2019
2	Minocycline (Cyclops)FDA LinkGeneric 02/2020 - 12/2019
2	LigandsIBA 01/2020 - 04/2018
2	artemisinin (artemisinine)IBA 10/2019 - 11/2017
2	PolymersIBA 10/2019 - 04/2018
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2018 - 11/2017
2	Singlet OxygenIBA 04/2018 - 08/2017
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2017 - 02/2017
1	5,11-methenyltetrahydrohomofolateIBA 03/2021
1	Lipid NanoparticlesIBA 03/2021
1	Acetic Acid (Vinegar)FDA LinkGeneric 03/2021
1	5-methyltetrahydrofolateIBA 03/2021
1	galanginIBA 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Immunoglobulin E (IgE)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	OvalbuminIBA 01/2020
1	2-chloro-5-nitrobenzanilideIBA 01/2020
1	PPAR gammaIBA 01/2020
1	Surface-Active Agents (Surfactants)IBA 10/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2019
1	Interleukin-1 (Interleukin 1)IBA 12/2018
1	AutoantibodiesIBA 12/2018
1	CytokinesIBA 12/2018
1	Interleukin-6 (Interleukin 6)IBA 12/2018
1	Interleukin-8 (Interleukin 8)IBA 12/2018
1	Interleukin-10 (Interleukin 10)IBA 12/2018
1	tocophersolanIBA 04/2018
1	hypocrellin BIBA 04/2018
1	SilverIBA 04/2018
1	Photosensitizing Agents (Photosensitizers)IBA 04/2018
1	Antineoplastic Agents (Antineoplastics)IBA 04/2018
1	monomethoxypolyethylene glycol (MPEG)IBA 03/2018
1	Antimalarials (Antimalarial Agents)IBA 11/2017
1	ResveratrolIBA 02/2017
1	MMEIBA 12/2014

Therapy/Procedure

5	Therapeutics 05/2023 - 11/2017
1	Oral Administration 01/2020
1	Intravenous Administration 12/2019